Explore Products

My Quote Request

No products added yet

6505-01-083-5984

20 Products

NDC00615-0561-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

View More Info

NDC00615-0561-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

MFG

MEDICAL TECHNOLOGIES SYSTEM INC VANGARD LABS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.600 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00777-0303-02

ERYTHROMYCIN TABLETS,USP

NSN, MFG P/N

6505010826773

NSN

6505-01-082-6773

View More Info

NDC00777-0303-02

ERYTHROMYCIN TABLETS,USP

NSN, MFG P/N

6505010826773

NSN

6505-01-082-6773

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: MA-93-79
MANUFACTURERS CODE: 24065
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:

2A6554

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

View More Info

2A6554

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT AND 25.000 MILLIEQUIVALENTS CHLORIDE PER LITER AND 5.000 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 7.500 MILLIMOLES PHOSPHATE PER LITER AND 15.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 25.000
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 1000ML 6S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 0.59 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED IV SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENTS SODIUM PER LITER AND 54.000 MILLIEQUIVALENT ACETATE PER LITER

NDC00338-0627-04

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

View More Info

NDC00338-0627-04

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT AND 25.000 MILLIEQUIVALENTS CHLORIDE PER LITER AND 5.000 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 7.500 MILLIMOLES PHOSPHATE PER LITER AND 15.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 25.000
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 1000ML 6S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 0.59 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED IV SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENTS SODIUM PER LITER AND 54.000 MILLIEQUIVALENT ACETATE PER LITER

TRAVASOL 3.5%

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

View More Info

TRAVASOL 3.5%

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT AND 25.000 MILLIEQUIVALENTS CHLORIDE PER LITER AND 5.000 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 7.500 MILLIMOLES PHOSPHATE PER LITER AND 15.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 25.000
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 1000ML 6S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 0.59 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED IV SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENTS SODIUM PER LITER AND 54.000 MILLIEQUIVALENT ACETATE PER LITER

TRAVASOL M

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

View More Info

TRAVASOL M

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT AND 25.000 MILLIEQUIVALENTS CHLORIDE PER LITER AND 5.000 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 7.500 MILLIMOLES PHOSPHATE PER LITER AND 15.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 25.000
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 1000ML 6S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 0.59 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED IV SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENTS SODIUM PER LITER AND 54.000 MILLIEQUIVALENT ACETATE PER LITER

TRAVASOL M WITH ELECTROLYTES 3.5

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

View More Info

TRAVASOL M WITH ELECTROLYTES 3.5

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010828870

NSN

6505-01-082-8870

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT AND 25.000 MILLIEQUIVALENTS CHLORIDE PER LITER AND 5.000 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 7.500 MILLIMOLES PHOSPHATE PER LITER AND 15.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 25.000
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 1000ML 6S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 0.59 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED IV SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENTS SODIUM PER LITER AND 54.000 MILLIEQUIVALENT ACETATE PER LITER

NDC00078-0017-15

BROMOCRIPTINE MESYLATE TABLETS,USP

NSN, MFG P/N

6505010830900

NSN

6505-01-083-0900

View More Info

NDC00078-0017-15

BROMOCRIPTINE MESYLATE TABLETS,USP

NSN, MFG P/N

6505010830900

NSN

6505-01-083-0900

MFG

NOVARTIS PHARMACEUTICALS CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS BROMOCRIPTINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BROMOCRIPTINE MESYLATE TABLETS USP 2.5MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

PARLODEL

BROMOCRIPTINE MESYLATE TABLETS,USP

NSN, MFG P/N

6505010830900

NSN

6505-01-083-0900

View More Info

PARLODEL

BROMOCRIPTINE MESYLATE TABLETS,USP

NSN, MFG P/N

6505010830900

NSN

6505-01-083-0900

MFG

NOVARTIS PHARMACEUTICALS CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS BROMOCRIPTINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BROMOCRIPTINE MESYLATE TABLETS USP 2.5MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC39822-0412-06

TOBRAMYCIN FOR INJECTION,USP

NSN, MFG P/N

6505010831038

NSN

6505-01-083-1038

View More Info

NDC39822-0412-06

TOBRAMYCIN FOR INJECTION,USP

NSN, MFG P/N

6505010831038

NSN

6505-01-083-1038

MFG

X-GEN PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.200 GRAMS TOBRAMYCIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOBRAMYCIN SULFATE STERILE USP POWDER FORM 1.2GM VIAL 6S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.200 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: WHEN RECONSTITUTED TO 30 ML EACH ML CONTAINS 40 MG OF TOBRAMYCIN; VIAL WITH A RATED CAPACITY OF NOT LESS THAN 40 ML
TOTAL PRIMARY CONTAINER QUANTITY: 6

NDC63323-0303-51

TOBRAMYCIN FOR INJECTION,USP

NSN, MFG P/N

6505010831038

NSN

6505-01-083-1038

View More Info

NDC63323-0303-51

TOBRAMYCIN FOR INJECTION,USP

NSN, MFG P/N

6505010831038

NSN

6505-01-083-1038

MFG

VETERANS HEALTH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.200 GRAMS TOBRAMYCIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOBRAMYCIN SULFATE STERILE USP POWDER FORM 1.2GM VIAL 6S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.200 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: WHEN RECONSTITUTED TO 30 ML EACH ML CONTAINS 40 MG OF TOBRAMYCIN; VIAL WITH A RATED CAPACITY OF NOT LESS THAN 40 ML
TOTAL PRIMARY CONTAINER QUANTITY: 6

NEBCIN

TOBRAMYCIN FOR INJECTION,USP

NSN, MFG P/N

6505010831038

NSN

6505-01-083-1038

View More Info

NEBCIN

TOBRAMYCIN FOR INJECTION,USP

NSN, MFG P/N

6505010831038

NSN

6505-01-083-1038

MFG

X-GEN PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.200 GRAMS TOBRAMYCIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOBRAMYCIN SULFATE STERILE USP POWDER FORM 1.2GM VIAL 6S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.200 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: WHEN RECONSTITUTED TO 30 ML EACH ML CONTAINS 40 MG OF TOBRAMYCIN; VIAL WITH A RATED CAPACITY OF NOT LESS THAN 40 ML
TOTAL PRIMARY CONTAINER QUANTITY: 6

ACID MANTLE CREME

ALUMINUM ACETATE CREAM

NSN, MFG P/N

6505010835938

NSN

6505-01-083-5938

View More Info

ACID MANTLE CREME

ALUMINUM ACETATE CREAM

NSN, MFG P/N

6505010835938

NSN

6505-01-083-5938

MFG

SANDOZ CONSUMER HEALTH CARE GROUP

Description

PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SANDOZ

NDC00043-0904-04

ALUMINUM ACETATE CREAM

NSN, MFG P/N

6505010835938

NSN

6505-01-083-5938

View More Info

NDC00043-0904-04

ALUMINUM ACETATE CREAM

NSN, MFG P/N

6505010835938

NSN

6505-01-083-5938

MFG

SANDOZ CONSUMER HEALTH CARE GROUP

Description

PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SANDOZ

NDC00002-1013-02

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

View More Info

NDC00002-1013-02

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.600 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00074-3781-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

View More Info

NDC00074-3781-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

MFG

ABBOTT LABORATORIES DIV ABBOTT DIAGNOSTICS DIVISION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.600 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00143-1201-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

View More Info

NDC00143-1201-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

MFG

WEST-WARD PHARMACEUTICAL CORP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.600 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00172-2047-60

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

View More Info

NDC00172-2047-60

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

MFG

ZENITH LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.600 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00536-3494-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

View More Info

NDC00536-3494-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.600 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00591-0944-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

View More Info

NDC00591-0944-01

COLCHICINE TABLETS,USP

NSN, MFG P/N

6505010835984

NSN

6505-01-083-5984

MFG

DANBURY PHARMACAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.600 MILLIGRAMS COLCHICINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE